Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-06-20

Clinical Trial Update: A New Method to Treat Hereditary Cerebellar Ataxia - Umbilical Cord Mesenchymal Stem Cells Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigates treating hereditary cerebellar ataxia with Umbilical Cord Mesenchymal Stem Cells transplantation, sponsored by the General…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical Cord Mesenchymal Stem Cells Transplantation

Snippet

Sponsor: General Hospital of Chinese Armed Police Forces | Conditions: Hereditary Cerebellar Ataxia. | Phase 2 | Status: UNKNOWN